HLS Therapeutics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Toronto, ON CAN
Total Funding:$155M
Industry:Pharma
Founded:2015
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • HLS Therapeutics's estimated annual revenue is currently $15.9M per year.
  • HLS Therapeutics received $125.0M in venture funding in September 2018.
  • HLS Therapeutics's estimated revenue per employee is $201,000
  • HLS Therapeutics's total funding is $155M.

Employee Data

  • HLS Therapeutics has 79 Employees.
  • HLS Therapeutics grew their employee count by 52% last year.
  • HLS Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Turnkey Modular...
$8.6M4326%N/A
PharmEng Techno...
$39.6M19713%N/A
Allphase Clinic...
$9.4M4715%N/A
Janssen
$1808.8M89997%N/A
Fresenius Kabi ...
$27.3M13621%N/A
Ontario Pharmac...
$1.2M6N/AN/A
Everest Clinica...
$41.2M20517%N/A
Robarts Clinica...
$60.7M30214%N/A
Novapharm Limit...
$23.5M1173%N/A
Dalton Pharma S...
$31.6M1575%N/A
Missing a competitor? Contribute!?
Submit

The Heritage of Life Sciences Products HLS Therapeutics is about maintaining the heritage of life science products. We are dedicated to keeping trusted branded drugs on the market. HLS provides access to medications critical to Health Care Providers, patients and their caregivers with the high-quality brand names they trust. Who We Are HLS Therapeutics Inc. is a specialty pharmaceutical company dedicating itself to acquiring and distributing commercial stage mature, or legacy, branded pharmaceutical drugs for the North American markets. Our management team is comprised of seasoned pharmaceutical executives with a strong track record of success. Building on the expertise of our founders, HLS is focused on treatment products for the central nervous system, soon to be followed by specialty products in other therapeutic areas. HLS Therapeutics focuses on the North American market and has operational locations in Toronto (Etobicoke, Ontario), and Philadelphia (Rosemont, Pennsylvania), We source our products from the drug's originator or from best-in-class manufacturing partners, ensuring our brands are manufactured with the highest standards of quality and in compliance with FDA and Health Canada's regulations. Our Goal/Our Mission HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycle during and post exclusivity, providing access to treatments critical to Health Care Providers, patients and their caregivers with the brand names they trust.

keywords:N/A

79

Number of Employees

$15.9M

Revenue (est)

1

Current Jobs

52%

Employee Growth %

$155M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Alec WilsonBrand Manager ClozarilEmail Available
Hemanth VargheseHead Of Corporate Strategy & Business DevelopmentEmail Available
Elizabeth FryManager, Therapeutic Area Development Email Available
Ryan LennoxGeneral CounselEmail Available
David IwanickiDirector Of National Accounts And Rsap ProgramEmail Available
Greg GubitzChief Executive OfficerEmail Available
Gilbert GodinPresident and Chief Operating Officer Email Available
Tim HendricksonChief Financial OfficerEmail Available
Hemanth VargheseHead of Corporate Strategy and Business Development
sanjiv SharmaChief Commercial OfficerEmail Available

HLS Therapeutics News

09/03/2019 - Update: HLS Therapeutics (TSE:HLS) Stock Gained 79% In The Last Year

HLS Therapeutics Inc. (TSE:HLS) shareholders might be concerned after seeing the share price drop 18% in the last month. But looking back ...

09/08/2019 - Should HLS Therapeutics Inc. (TSE:HLS) Be Part Of Your Income Portfolio?

HLS Therapeutics has only been paying a dividend for a year or so, so investors might be curious about its 1.4% yield.” Before you buy any ...

09/03/2019 - Trading Watch: Reviewing the Numbers for HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Inc. (TSX:HLS) has a current EV or Enterprise Value of 457566. The EV displays how the market assigns value to a firm as a ...

HLS Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-09-13$125.0MUndisclosedSilicon Valley BankArticle